Alkermes Inc. plc

ALKSNASDAQ • USD
47.17 USD
↗ 0.14 (0.29%)🟢LIVE (AS OF 12:55 PM EST)
🟢Market: OPEN

ALKS is currently priced at $47.17. ALKS shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". This is driven by a weak Piotroski F-Score of 2/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, ALKS trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 13, 2026.

Open?$47.02
High?$47.88
Low?$46.40
Prev. Close?$47.03
Volume?251.4K
Avg. Volume?1.9M
VWAP?$47.21
Rel. Volume?0.13x
Bid / Ask
Bid?$47.09 × 100
Ask?$47.37 × 100
Spread?$0.28
Midpoint?$47.23
Valuation & Ratios
Market Cap?7.9B
Shares Out?168.0M
Float?165.1M
Float %?98.4%
P/E Ratio?N/A
P/B Ratio?4.24
EPS?-$0.00
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Employees
2.0K
Market Cap
7.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1991-07-16
Address
CONNAUGHT HOUSE
DUBLIN 4, L2 00000
Phone: 00-353-1-772-8000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
46
Momentum?
50
Short Sent.?
28
Piotroski F-Score?2/9Weak
Altman Z-Score?2.29Grey
Confidence?71%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?11.90%High
Short Interest?19.6M
Days to Cover?11.3
Free Float165.1M
Avg Daily Volume1.7M
Settlement Date2026-10-30
Financial Health
Current Ratio?2.42Strong
Quick Ratio?2.02Strong
Cash Ratio?0.97Adequate
Debt/Equity?0.80Moderate
ValuationFAIRLY VALUEDvs 4 peers + S&P 500
Score
60/100
P/E?
N/A▾
P/B?
Peers
40
S&P
42
4.24FAIR▾
P/S?
Peers
40
S&P
33
4.51FAIR▾
P/FCF?
Peers
25
S&P
22
34.8FAIR▾
EV/EBITDA?
Peers
25
S&P
7
36.0HIGH▾
EV/Sales?
Peers
40
S&P
36
5.00FAIR▾
Returns & Efficiency
ROE?
Peers
25
S&P
15
-0.0%WEAK▾
ROA?
Peers
25
S&P
8
-0.0%WEAK▾
Cash Flow & Enterprise
FCF?$227.4M
Enterprise Value?$8.8B
Fundamentals ratios updated end of day